Forus

Therapeutics

is a Canadian biopharmaceutical
company dedicated to advancing
differentiated, novel medicines
for hematologic malignancies
and other forms of cancer.

About Forus

Leadership

Values

Latest News

XPOVIO® Now Funded in Quebec

XPOVIO® Now Funded in Quebec

FORUS Therapeutics Inc. is pleased to announce that XPOVIO® (selinexor) is now publicly funded in Quebec as of November 6th. Further details on the criteria can be found in the links below: Liste des médicaments - Établissement - en vigueur le 6 novembre 2025 Liste...

WELCOME, Lisa Kolomaya

FORUS Therapeutics is thrilled to welcome Lisa Kolomaya as Therapeutic Area Manager, Hematology/Oncology, AB/SK. Lisa is a results-driven life sciences professional with extensive expertise in both oncology and hematology. Guided by a strategic mindset and passion for...

WELCOME, Erin Webb

FORUS Therapeutics is thrilled to welcome Erin Webb as Therapeutic Area Manager, Hematology/Oncology, SW ON. Erin began her career as a physician assistant in the US, caring for patients with both benign and malignant hematologic conditions as well as managing...

Contact Us

Mailing Address:

FORUS Therapeutics Inc.
200 North Service Road West, Suite 129
Oakville, Ontario, L6M 2Y1

Phone: 1-877-359-9595
Fax: 1-877-359-9590

Patient Support:

Phone: 1-833-4YOUPSP (1-833-496-8777)
Fax: 1-833-4YOUFAX (1-833-496-8329)

Product Support:

Phone: 1-866-542-7500
Fax: 1-866-542-1100

Do not use this form to report adverse events. Adverse events can be reported at 1-866-542-7500.